1 in 5 reprocessed SUDs (single-use devices) pulled for failing validation
This article was originally published in Clinica
Executive Summary
Companies reprocessing single-use devices (SUDs) in the US are having trouble complying with the FDA's new requirement that validation data be provided for certain potentially risky products already on the market, agency officials have told Clinica.